Evidence map›Paper›PMID 40124036›Full record

ArticleACS omega2025

A 96-Well Polyacrylamide Gel for Electrophoresis and Western Blotting.

Marc R Birtwistle, Jonah R Huggins, Cameron O Zadeh, Deepraj Sarmah, Sujata Srikanth, B Kelly Jones, Lauren N Cascio, Delphine Dean

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Marc R BirtwistleBlotting Innovations, 158 W Old Pendleton Rd., Central, South Carolina 29630, United States.ORCID https://orcid.org/0000-0002-0341-0705
Jonah R HugginsBlotting Innovations, 158 W Old Pendleton Rd., Central, South Carolina 29630, United States.
Cameron O ZadehBlotting Innovations, 158 W Old Pendleton Rd., Central, South Carolina 29630, United States.
Deepraj SarmahBlotting Innovations, 158 W Old Pendleton Rd., Central, South Carolina 29630, United States.
Sujata SrikanthDepartment of Bioengineering, 118 Engineering Service Dr., Clemson University, Clemson, South Carolina 29634, United States.
B Kelly JonesDepartment of Bioengineering, 118 Engineering Service Dr., Clemson University, Clemson, South Carolina 29634, United States.
Lauren N CascioDepartment of Bioengineering, 118 Engineering Service Dr., Clemson University, Clemson, South Carolina 29634, United States.
Delphine DeanDepartment of Bioengineering, 118 Engineering Service Dr., Clemson University, Clemson, South Carolina 29634, United States.

Funding

Accessible and Robust High-Throughput Western Blotting for Small Sample SizesR41GM148112 · NIGMS · BLOTTING INNOVATIONS, LLC · PI BIRTWISTLE, MARC R. · 2022 to 2022
$289k
NIGMS NIH HHS R41 GM148112
6 · The paper itself

Abstract

Western blotting is a stalwart technique for analyzing specific proteins and their post-translational modifications. However, it remains challenging to accommodate more than ∼10 samples per experiment without a substantial departure from trusted, established protocols involving accessible instrumentation. Here, we describe a 96-sample Western blot that conforms to standard 96-well plate dimensional constraints and has little operational deviation from standard Western blotting. The main differences are that (i) submerged polyacrylamide gel electrophoresis is operated horizontally (similar to agarose gels) as opposed to vertically and (ii) a 6 mm thick gel is used, with 2 mm most relevant for membrane transfer (vs ∼1 mm typical). Results demonstrate that both wet and semidry transfer are compatible with this gel thickness. The major trade-off is reduced molecular weight resolution, due primarily to less available migration distance per sample. We demonstrate proof-of-principle using gels loaded with a molecular weight ladder, recombinant protein, and cell lysates. We expect that the 96-well Western blot will increase reproducibility, efficiency (cost and time ∼8-fold), and capacity for biological characterization relative to established Western blots.

Identifiers

PMID40124036
PMCPMC11923646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.